Stay updated on Aducanumab for Early Alzheimer's: Clinical Trial
Sign up to get notified when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.

Latest updates to the Aducanumab for Early Alzheimer's: Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.4.3 updated, replacing the previous v3.4.2.SummaryDifference0.0%

- Check10 days agoChange DetectedNo additions or deletions were specified for this page.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page revision was updated from v3.4.1 to v3.4.2; no other content changes are apparent. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check32 days agoChange DetectedAdded a new related publication citation for the aducanumab Phase 3 trials and updated the revision to v3.4.1, replacing the prior revision (v3.4.0) and its erratum; this update affects only documentation and revision history, not the study's core design or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check54 days agoChange Detected- Revision history updated: v3.3.4 added; v3.3.3 entry removed.SummaryDifference0.0%

- Check61 days agoChange DetectedPublications section updated: a related publication entry was added with an Erratum (Apr 2023) and the earlier February 2023 entry was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Aducanumab for Early Alzheimer's: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.